Bigelow Investment Advisors, LLC Abb Vie Inc. Transaction History

Bigelow Investment Advisors, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 31, 2024	BUY	$137.6 - $154.97 $226,764 - $255,390	1,648 New	1,648 $255,000
Q4 2022 Jan 26, 2023	SELL	$138.31 - $165.87 $41,493 - $49,761	-300 Reduced 17.08%	1,456 $0
Q2 2022 Jul 18, 2022	SELL	$137.62 - $174.96 $1,376 - $1,749	-10 Reduced 0.57%	1,756 $269,000
Q1 2022 Apr 29, 2022	BUY	$131.98 - $163.75 $1,451 - $1,801	11 Added 0.63%	1,766 $286,000
Q4 2021 Feb 11, 2022	BUY	$107.43 - $135.93 $188,539 - $238,557	1,755 New	1,755 $238,000
Q3 2021 Nov 04, 2021	SELL	$106.4 - $120.78 $218,652 - $248,202	-2,055 Closed	0 $0
Q2 2021 Aug 09, 2021	BUY	$105.21 - $117.21 $5,260 - $5,860	50 Added 2.49%	2,055 $231,000
Q4 2020 Feb 12, 2021	BUY	$80.49 - $108.67 $161,382 - $217,883	2,005 New	2,005 $215,000
Q3 2020 Nov 10, 2020	SELL	$85.91 - $100.83 $178,263 - $209,222	-2,075 Closed	0 $0
Q2 2020 Aug 11, 2020	BUY	$73.37 - $98.18 $152,242 - $203,723	2,075 New	2,075 $204,000
Q1 2020 May 05, 2020	SELL	$64.5 - $97.79 $160,282 - $243,008	-2,485 Closed	0 $0
Q4 2019 Jan 31, 2020	BUY	$72.13 - $90.25 $179,243 - $224,271	2,485 New	2,485 $220,000

3,943

1.26B

16.8M

12.1M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $337B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Bigelow Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Bigelow Investment Advisors, LLC with notifications on news.